Endocrinology

The CGTLive™ Endocrinology specialty topic page houses video interviews with key opinion leaders in the field of endocrinology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for endocrine disorders. It also contains up-to-date clinical news coverage in the field of endocrinology gene and cell therapy.

Latest News

Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024

November 20th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

World Diabetes Day 2024: Looking Back at Progress for Cell and Gene Therapy
World Diabetes Day 2024: Looking Back at Progress for Cell and Gene Therapy

November 14th 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 13, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 13, 2024

November 13th 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 6, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 6, 2024

November 6th 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 30, 2024
Around the Helix: Cell and Gene Therapy Company Updates – October 30, 2024

October 30th 2024

Video Interviews

More News

Around the Helix: Cell and Gene Therapy Company Updates – October 23, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 23, 2024

Noah Stansfield
October 23rd 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – October 16, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 16, 2024

Noah Stansfield
October 16th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – October 9, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 9, 2024

Noah Stansfield
October 9th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024

Noah Stansfield
October 2nd 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – September 25, 2024

Around the Helix: Cell and Gene Therapy Company Updates – September 25, 2024

Noah Stansfield
September 25th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – September 18, 2024

Around the Helix: Cell and Gene Therapy Company Updates – September 18, 2024

Noah Stansfield
September 18th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

ProKidney Puts Focus on US Trial for T2D and CKD Cell Therapy Rilparencel

ProKidney Puts Focus on US Trial for T2D and CKD Cell Therapy Rilparencel

Noah Stansfield
September 12th 2024

The company also reported that it is discontinuing the phase 3 REGEN-016 (PROACT 2) clinical trial evaluating rilparencel in Spain.

Around the Helix: Cell and Gene Therapy Company Updates – September 11, 2024

Around the Helix: Cell and Gene Therapy Company Updates – September 11, 2024

Noah Stansfield
September 11th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – September 4, 2024

Around the Helix: Cell and Gene Therapy Company Updates – September 4, 2024

Noah Stansfield
September 4th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Amarna Therapeutics Secures Regulatory Guidance From FDA for Diabetes Gene Therapy AM510

Amarna Therapeutics Secures Regulatory Guidance From FDA for Diabetes Gene Therapy AM510

Noah Stansfield
August 29th 2024

Amarna noted that the meeting, which took place on July 31, 2024, provided the company with feedback on the overall development plan for AM510.

Around the Helix: Cell and Gene Therapy Company Updates – August 28, 2024

Around the Helix: Cell and Gene Therapy Company Updates – August 28, 2024

Noah Stansfield
August 28th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – August 14, 2024

Around the Helix: Cell and Gene Therapy Company Updates – August 14, 2024

Noah Stansfield
August 14th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – August 7, 2024

Around the Helix: Cell and Gene Therapy Company Updates – August 7, 2024

Noah Stansfield
August 7th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – July 31, 2024

Around the Helix: Cell and Gene Therapy Company Updates – July 31, 2024

Noah Stansfield
July 31st 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – July 24, 2024

Around the Helix: Cell and Gene Therapy Company Updates – July 24, 2024

Noah Stansfield
July 24th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – July 17, 2024

Around the Helix: Cell and Gene Therapy Company Updates – July 17, 2024

Noah Stansfield
July 17th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – July 10, 2024

Around the Helix: Cell and Gene Therapy Company Updates – July 10, 2024

Noah Stansfield
July 10th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Data Roundup: June 2024 Features Updates from ASCO and in Diabetes, Rare Disease, and more.

Data Roundup: June 2024 Features Updates from ASCO and in Diabetes, Rare Disease, and more.

Victoria Johnson
July 9th 2024

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

Around the Helix: Cell and Gene Therapy Company Updates – July 3, 2024

Around the Helix: Cell and Gene Therapy Company Updates – July 3, 2024

Noah Stansfield
July 3rd 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – June 26, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 26, 2024

Noah Stansfield
June 26th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Vertex’s Diabetes Cell Therapy on Track to Meet Endpoint of Eliminating Severe Hypoglycemic Events

Vertex’s Diabetes Cell Therapy on Track to Meet Endpoint of Eliminating Severe Hypoglycemic Events

Victoria Johnson
June 26th 2024

All 3 participants who have follow-up of at least 1 year have met the endpoint so far.

Gene Therapy Improves Body Composition in Mice Models of Obesity Alone and After Semaglutide Withdrawal

Gene Therapy Improves Body Composition in Mice Models of Obesity Alone and After Semaglutide Withdrawal

Victoria Johnson
June 23rd 2024

Fractyl Health is conducting IND-enabling studies for Rejuva.

Around the Helix: Cell and Gene Therapy Company Updates – June 19, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 19, 2024

Noah Stansfield
June 19th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – June 12, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 12, 2024

Noah Stansfield
June 12th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – June 5, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 5, 2024

Noah Stansfield
June 5th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Kevin Zinchuk, PharmD, CCRP, Pharmacy Manager, Investigational Drug Services, Brigham and Women’s Hospital.

Safe Handling Guidelines Needed for Gene Therapies in the Clinic

Victoria Johnson
May 31st 2024

Current handling guidelines do not align between the laboratory and clinical settings.

Around the Helix: Cell and Gene Therapy Company Updates – May 29, 2024

Around the Helix: Cell and Gene Therapy Company Updates – May 29, 2024

Noah Stansfield
May 29th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Carolyn Riley Chapman, PhD, MS, Lead Investigator, Division of Global Health Equity (DGHE), Multi-Regional Clinical Trials (MRCT) Center, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School

Ethical Framework Needed for Gene Therapy Clinical Trials

Victoria Johnson
May 29th 2024

An ASGCT poster focused on special ethical considerations of gene therapy human research and how to address them.

Around the Helix: Cell and Gene Therapy Company Updates – May 22, 2024

Around the Helix: Cell and Gene Therapy Company Updates – May 22, 2024

Noah Stansfield
May 22nd 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Omer A. Abdul Hamid, MD

Considerations for Gene Therapy Logistics and Implementation

Victoria Johnson
May 16th 2024

Omer A. Abdul Hamid, MD, pediatric neurologist at Nemours Children’s Health offered advice and discussed important practical considerations with administering gene therapies.

1234>
© 2024 MJH Life Sciences

All rights reserved.